Impact of migraine attacks on the blood-brain barrier

Chinese Medical Journal

Volumn 123, Issue 18, 2010, Pages 2559-2561

  Goa, Hong Mei ^a   Li, Le ^a   Zhang, Ke Ling ^a   Chen, Xu Hui ^a   Tian, Shu Qing ^a   Zhang, Zhong Ling ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Blood brain barrier; Matrix metalloproteinase 9; Migraine

Indexed keywords

GELATINASE B;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BLOOD SAMPLING; BRAIN FUNCTION; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOUBLE ANTIBODY SANDWICH ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEADACHE; HUMAN; MALE; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NEUROANATOMY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADULT; BLOOD-BRAIN BARRIER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MIGRAINE DISORDERS; YOUNG ADULT;

EID: 79851503482     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.18.012     Document Type: Article

References (22)

1. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993; 33: 48-56.
2. Gupta VK. CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine. Expert Rev Neurother 2009; 9: 1595-1614.
3. Teepker M, Munk K, Mylius V, Haag A, Möller JC, Oertel WH, et al. Serum concentrations of s100b and NSE in migraine. Headache 2009; 49: 245-252.
4. Wieseler J, Ellis A, Sprunger D, Brown K, McFadden A, Mahoney J, et al. A novel method for modeling facial allodynia associated with migraine in awake and freely moving rats. J Neurosci Methods 2010; 185: 236-245.
5. Dreier JP, Jurkat-Rott K, Petzold GC, Tomkins O, Klingebiel R, Kopp UA, et al. Opening of the blood-brain barrier preceding cortical edema in a severe attack of FHM type II. Neurology 2005; 64: 2145-2147.
6. Castillo J, Leira R, Blanco M. Metalloproteinases and neurovascular injury. Neurologia 2004; 19: 312-320.
7. Mun-Bryce S, Rosenberg GA. Rosenberg Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am J Physiol 1998; 274 (5 Pt 2): R1203-R1211.
8. Olesen J, Steiner TJ. The international classification of headache disorders, 2nd edn (ICDH-II). J Neurol Neurosurg Psychiatry 2004; 75: 808-811.
9. Moskowitz MA, Bolay H, Dalkara T. Deciphering migraine mechanisms: clues from familial hemiplegic migraine genotypes. Ann Neurol 2004; 55: 276-280.
10. Mannello F. New implications of the proteolytic balance between matrix metalloproteinases and their tissue inhibitors in migraine with and without aura. Clin Chim Acta 2009; 409: 13.
11. Wang JF, Wang Q, Zhao LH, Shi GZ, Zhou JX. Blood-brain barrier penetration of cefepime after neurosurgery. Chin Med J 2007; 120: 1176-1178.
12. Gursoy-Ozdemir Y, Qiu J, Matsuoka N, Bolay H, Bermpohl D, Jin H, et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 2004; 113: 1447-1455.
13. Leira R, Sobrino T, Rodríguez-Yáñez M, Blanco M, Arias S, Castillo J. MMP-9 immunoreactivity in acute migraine. Headache 2007; 47: 698-702.
14. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 2003; 253: 269-285.
15. Edvinsson L, Tfelt-Hansen P. The blood-brain barrier in migraine treatment. Cephalalgia 2008; 28: 1245-1258.
16. Tfelt-Hansen PC. Does sumatriptan cross the blood-brain barrier in animals and man? J Headache Pain 2010; 11: 5-12.
17. Guan JX, Sun SG, Cao XB, Chen ZB, Tong ET. Effect of thrombin on blood brain barrier permeability and its mechanism. Chin Med J 2004; 117: 1677-1681.
18. Nikai T, Basbaum AI, Ahn AH. Profound reduction of somatic and visceral pain in mice by intrathecal administration of the anti-migraine drug, sumatriptan. Pain 2008; 139: 533-540.
19. Edvinsson L. CGRP blockers in migraine therapy: where do they act? Br J Pharmacol 2008; 155: 967-969.
20. Kniesel U, Wolburg H. Tight junctions of the blood-brain barrier. Cell Mol Neurobiol 2000; 20: 57-76.
21. Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 2001; 21: 7724-7732.
22. He ZJ, Huang ZT, Chen XT, Zou ZJ. Effects of matrix metalloproteinase 9 inhibition on the blood brain barrier and inflammation in rats following cardiopulmonary resuscitation. Chin Med J 2009; 122: 2346-2351.